| Document |
Document Title |
|
WO/2003/084942A2 |
The present invention describes the synthesis of the following compounds in high stereochemical purity by a novel stereoselective alkylation of 2-methyl-4-protected piperazines using an inorganic base. (I)
|
|
WO/2003/082205A2 |
Disclosed is a compound having the formula (I) pharmaceutically acceptable salts or solvates thereof and pharmaceutical compositions containing the same, wherein the structural variables are as defined herein. The compounds, salts and so...
|
|
WO/2003/082781A1 |
In a process for oligomerizing a C2 to C6 n-olefin feedstock over surface deactivated ZSM-23, the feedstock contains from about 0.1 wt% to about 25 wt% of an iso-olefin and the C12+ fraction of the oligomerized olefin product contains le...
|
|
WO/2003/082883A1 |
The invention aims at providing titanium salts which are properly and stably dispersible or soluble in both oil and water and titanium salts which can be used as raw material of various titanium-containing materials or as catalysts for v...
|
|
WO/2003/082783A1 |
A process for producing phenyl-alkanes, the process comprising the steps of: a) passing a feed stream comprising a first concentration of a first acyclic paraffin having a carbon range of C¿8?-C¿28? and 2 or 3 primary carbon atoms and ...
|
|
WO/2003/082782A1 |
In a process for preparing an alkylaromatic hydrocarbon composition an olefinic hydrocarbon mixture and an aromatic compound are contacted under alkylation conditions with an aromatic alkylation catalyst selected from a homogeneous acid ...
|
|
WO/2003/082812A2 |
A process for the preparation of a compound of formula (I); in which R represents H or an acid protecting group which comprises reacting a compound of formula (II); in which R is as previously defined with a compound of formula (III); wh...
|
|
WO/2003/082811A1 |
The present invention relates to a method for preparing monoglyceride sulfonate that is useful for a cleansing agent for a human body, economically in a large amount, from an inexpensive fatty acid using a convenient manufacturing unit. ...
|
|
WO/2003/082778A1 |
A process for preparing a substantially linear olefinic hydrocarbon mixture is described in which a lower olefin feed comprising one or more C3 to C6 lower olefins is contacted in the presence of water and under olefin oligomerization co...
|
|
WO/2003/082779A1 |
In a process for preparing an olefinic hydrocarbon mixture comprising at least 5% by weight of mono-olefin oligomers of the empirical formula; CnH2n where n greater than or equal to 6, a feedstock comprising n-butene and propylene in a m...
|
|
WO/2003/079984A2 |
The present invention pertains, at least in part, to novel substituted tetracycline compounds. These tetracycline compounds can be used to treat numerous tetracycline compound-responsive states, such as bacterial infections and neoplasms...
|
|
WO/2003/080542A2 |
The invention relates to a method for producing 3-hydroxy-2-methylbenzoic acid or solutions containing salts of 3-hydroxy-2-methylbenzoic acid, with naphthalene as the starting substance. Said method essentially comprises the following s...
|
|
WO2003029199A9 |
Novel benzene derivatives represented by the general formula (||), which exhibit vanilloid receptor agonism and are useful as preventive and therapeutic drugs for pollakisuria and urinary incontinence, analgesic, or the like: (||) wherei...
|
|
WO/2003/074008A2 |
The present invention encompasses compounds of formula (II); as well as the pharmaceutically acceptable salts and hydrates thereof. The compounds are useful for treating immune mediated diseases and conditions, such as bone marrow, organ...
|
|
WO/2003/073986A2 |
The present invention encompasses compounds of Formula (I): as well as the pharmaceutically acceptable salts and hydrates thereof. The compounds are useful for treating immune mediated diseases and conditions, such as bone marrow, organ ...
|
|
WO/2003/074470A1 |
A process for producing tert-leucine characterized by reacting tert-leucine with a substituted benzenesulfonic acid represented by the following general formula (1): (1) (wherein R1 and R2 each independently represents hydrogen, alkyl, o...
|
|
WO/2003/070681A1 |
A process for the production of metal salts of radical-polymerizable compounds having lowered water contents, characterized by heating (A) an aqueous solution of a salt of acrylic or methacrylic acid with an alkali or alkaline earth meta...
|
|
WO/2003/070714A1 |
The present invention relates to a method for the synthesis of highly fluorinated compounds and to novel highly fluorinated compounds. In particular, the present invention relates to the synthesis of highly fluorinated acetals and ketals...
|
|
WO/2003/067332A2 |
Chemically amplified photoresist compositions comprising, (a) a compound which cures upon the action of an acid or a compound whose solubility is increased upon the action of an acid&semi and (b) a compound of the formula (Ia), (Ib), (II...
|
|
WO/2003/064369A1 |
It is intended to provide compounds represented by the following general formula (I) which have a high affinity for human thyroid hormone receptors, in particular, human thyroid hormone receptor β, medicinal compositions containing the ...
|
|
WO/2003/064380A1 |
Trifluoromethylbenzenesulfonyl chlorides represented by the general formula (3): (3) [wherein X and Y are each independently hydrogen or halogeno] are produced by reacting a benzotrifluoride represented by the general formula (1): (1) [w...
|
|
WO/2003/062190A1 |
The following compounds of formulae (I) and (III) which may be useful in treating a variety of cell proliferative disorders are disclosed: Fomula (I), (II), wherein R1, R2 and R3 are each independently selected from H, OH, C1-6 alkyl, C1...
|
|
WO/2003/059869A1 |
A process for easily and industrially advantageously producing a high-purity 2-aralkyl-3-acetylthiopropionic acid and a high-purity 2-aralkylpropionic acid having a leaving group in the 3-position from easily available compounds. A 2-ara...
|
|
WO/2003/053561A2 |
A process for the preparation of nanoscale particulate material is described comprising: (i) combining one or more functional material to be precipitated as nanoscale particles and one or more surface active material in a compressed CO2 ...
|
|
WO/2003/053918A2 |
The invention relates to a method for producing perfluoroalkane sulfonic acid esters and their subsequent conversion into salts, in addition to the use of the produced compounds in electrolytes and batteries, capacitors, supercapacitors ...
|
|
WO/2003/051894A1 |
Provided is a method for preparation of non-halide based ionic liquids, comprising reacting a halide salt of an organic cation with a Bronsted acid in the presence of an alcohol or alkene or alkyne. The non-halide based ionic liquid prod...
|
|
WO/2003/051826A1 |
A compound of formula (I); wherein R1 represents chloro, fluoro or hydroxy as well as optical isomers and racemates thereof as well as pharmaceutically acceptable salts, prodrugs, solvates and crystalline forms thereof, to processes for ...
|
|
WO/2003/051825A1 |
The present invention provides compounds useful for inhibiting the ADAM-10 protein. Such compounds are useful in the in vitro study of the role of ADAM-10 (and its inhibition) in biological processes. The present invention also comprises...
|
|
WO/2003/049666A2 |
The present invention relates to the field of perfumery. More particularly, it concerns compounds comprising at least one $g(b)-oxy or $g(b)-thio carbonyl moiety capable of liberating a perfuming molecule such as, for example, an $g(a),$...
|
|
WO/2003/050073A1 |
Disclosed are compounds of the formula (I) and the pharmaceutically acceptable salts thereof wherein the variables G, L, A, W, E, R2, R3, R4, R5, RN, and RC are defined herein. These compounds interact with and inhibit the activity of th...
|
|
WO/2003/048116A2 |
The present invention relates to novel antidiabetic, hypolipidemic, antiobesity and hypocholesterolemic compounds of formula (I), their derivatives, their analogs, their tautomeric forms, their stereoisomers, their polymorphs, their phar...
|
|
WO/2003/046197A1 |
The invention relates to simple and efficient preparation of optically active 7−substituted−2−aminotetralins with industrial advantage. A process for preparation of optically active 7− substituted−2−aminotetralins or salts th...
|
|
WO/2003/045896A1 |
The present invention relates to a new process for the preparation of the ($i(S))-naproxen 4-nitrooxybutyl ester and to new intermediates obtained and used therein. The invention further relates to the use of the new intermediates for th...
|
|
WO/2003/043625A1 |
(R) and (S) 2-Aryl-propionic acids, and pharmaceutical compositions that contain them, are useful in inhibiting chemotactic activation of neutrophils (PMN leukocytes) induced by the interaction of Interleukin-8 (IL-8) with CXCR1 and CXCR...
|
|
WO/2003/042153A1 |
A pest control agent which is highly effective in pest control and is highly safe for crops, natural enemies to pests, and mammals. It is a difluoroalkene derivative represented by the following general formula [1] or a pharmacologically...
|
|
WO/2003/040087A1 |
A process for the preparation of 2-[alkyl(aryl)]sulfonylbenzene sulfonyl chlorides of the formula (I), in which R is alkyl or aryl substituted at the ortho or meta positions with alkyl, aryl, NHAc or alkoxy, comprising the steps of: a) r...
|
|
WO/2003/039456A2 |
Provided are processes for the synthesis of aniline derivatives, specifically certain aniline derivatives which have activity as thyroid receptor ligands.
|
|
WO/2003/040382A1 |
A process for easily producing from an inexpensive material various kinds of optically active chroman derivatives useful as intermediates for medicines, etc. A cyclic hemiacetal (1) obtained from dihydrocoumarin through one step is conve...
|
|
WO/2003/038164A2 |
The invention relates to a method for treating solvent-spun cellulose fibers during which the fibers are brought into contact with a textile auxiliary in an alkaline medium. The inventive method is characterized in that a compound of gen...
|
|
WO/2003/037852A1 |
Compounds of the formula (I) are useful in treating disease conditions mediated by TNF-&agr , such as rheumatoid arthritis, osteoarthritis, sepsis, AIDS, ulcerative colitis, multiple sclerosis, Crohn's disease, degenerative cartilage los...
|
|
WO/2003/035608A1 |
The compound of formula (I) is obtained via reaction of a compound of formula (III), or (VII), with a compound of formula (IV).
|
|
WO/2003/035013A1 |
An aqueous one−pack self−etching and self−priming dental adhesive composition having a pH of at most 2, which comprises: (i) a polymerizable N−substituted alkylacrylic or acrylic acid amide monomer which optionally contains an in...
|
|
WO/2003/034445A1 |
A novel proton conductor which is usable in dry atmosphere or in a relatively wide temperature range including room temperatures and is remarkably improved in proton conductivity&semi a process for the production thereof&semi and electro...
|
|
WO/2003/033461A1 |
The invention relates to intermediate products and a novel method for producing benzocycloheptene C. The inventive method for producing the novel intermediate products of said compound is based on cost-effective starting materials, produ...
|
|
WO/2003/033460A1 |
A novel, storage-stable, free-flowing, solid product consisting essentially of an alkyl benzene sulphonic acid having 1 to 4 aliphatic carbon atoms and from 7 to 11 % water based on the weight of the product, said alkyl benzene sulphonic...
|
|
WO/2003/029172A2 |
Alkylaryl compounds are produced by: a) preparing a C¿4? olefin mixture consisting of LPG, LNG or MTO flows; b1) reacting the C¿4? olefin mixture obtained thereby on a metathesis catalyst in order to produce an olefin mixture that cont...
|
|
WO/2003/028145A2 |
Disclosed are compositions prepared by free-radical-driven grafting onto hydrocarbons or hydrocarbon ethers of olefinically unsaturated fluorocarbons containing sulfonyl fluoride, fluorosulfonate, fluorosulfonimide, or fluorosulfonyl met...
|
|
WO/2003/027063A1 |
A process for the preparation of sulphonated phenols of general formula (I) where R¿1? is hydrogen, a C¿1?-C¿20? alkyl group which is unsubstituted or substituted by halogen, cyano, hydroxyl, C¿1?-C¿20? alkoxy, C¿2?-C¿20? alkoxyca...
|
|
WO/2003/027059A1 |
Acid amide derivatives represented by the formula (I) (I) [wherein A is phenyl optionally substituted by X, benzyl optionally substituted by X, naphthyl optionally substituted by X, a heterocyclic group optionally substituted by X, a fus...
|
|
WO/2003/024390A2 |
A hydroxyeicosenoic acid analog represented by the following Formula (I), the bond $m(Z) represents a cis-vinylene group or an ethynylene group; Y represents CH?2¿, O or S(O)?p¿ wherein p is 0, 1 or 2; m represents an integer of 1 to 4...
|
